ArticleNeurology2021
Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
Amit Bar-Or et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleNeurology2021
Amit Bar-Or et al.PubMed ↗Publisher ↗
No numbers read from the abstract.